 Hanan Elajaili
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electron Spin Resonance Spectroscopy | 16 | 2019 | 83 | 2.890 |
Why?
| | Nitrogen Oxides | 8 | 2017 | 56 | 1.350 |
Why?
| | Quinones | 2 | 2015 | 11 | 1.040 |
Why?
| | Trityl Compounds | 2 | 2014 | 3 | 0.650 |
Why?
| | Electrons | 2 | 2014 | 73 | 0.610 |
Why?
| | Nails | 1 | 2016 | 10 | 0.580 |
Why?
| | Radiometry | 1 | 2016 | 45 | 0.570 |
Why?
| | Temperature | 1 | 2019 | 622 | 0.550 |
Why?
| | Biological Assay | 1 | 2016 | 122 | 0.550 |
Why?
| | Disulfides | 1 | 2015 | 91 | 0.520 |
Why?
| | Alcohols | 1 | 2014 | 31 | 0.500 |
Why?
| | Sulfhydryl Compounds | 1 | 2015 | 179 | 0.460 |
Why?
| | Oxidation-Reduction | 5 | 2020 | 940 | 0.340 |
Why?
| | Bleomycin | 2 | 2021 | 228 | 0.330 |
Why?
| | Acute Lung Injury | 2 | 2021 | 310 | 0.310 |
Why?
| | Free Radicals | 3 | 2015 | 104 | 0.280 |
Why?
| | Oxidative Stress | 3 | 2022 | 1179 | 0.260 |
Why?
| | Cerium | 2 | 2021 | 12 | 0.250 |
Why?
| | Mitochondria | 2 | 2020 | 786 | 0.230 |
Why?
| | Oxygen | 4 | 2016 | 857 | 0.230 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 6 | 0.220 |
Why?
| | Antimycin A | 2 | 2020 | 13 | 0.220 |
Why?
| | Lung | 5 | 2022 | 3666 | 0.210 |
Why?
| | Deuterium | 4 | 2014 | 78 | 0.200 |
Why?
| | Superoxides | 2 | 2020 | 221 | 0.200 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 44 | 0.200 |
Why?
| | Myofibroblasts | 1 | 2022 | 120 | 0.190 |
Why?
| | Phantoms, Imaging | 3 | 2016 | 139 | 0.190 |
Why?
| | Catechin | 1 | 2020 | 26 | 0.180 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 21 | 0.180 |
Why?
| | Lung Injury | 1 | 2021 | 210 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2019 | 53 | 0.170 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 42 | 0.170 |
Why?
| | Algorithms | 3 | 2015 | 1543 | 0.170 |
Why?
| | Electromagnetic Fields | 2 | 2015 | 21 | 0.170 |
Why?
| | Equipment Failure Analysis | 2 | 2016 | 139 | 0.170 |
Why?
| | Spin Labels | 3 | 2014 | 50 | 0.170 |
Why?
| | Glioma | 1 | 2022 | 306 | 0.170 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2019 | 83 | 0.170 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 306 | 0.160 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 197 | 0.160 |
Why?
| | Nanoparticles | 1 | 2021 | 325 | 0.160 |
Why?
| | Equipment Design | 2 | 2016 | 519 | 0.150 |
Why?
| | Molecular Structure | 2 | 2017 | 459 | 0.150 |
Why?
| | Carboxylic Acids | 1 | 2017 | 30 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2016 | 1795 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2016 | 536 | 0.150 |
Why?
| | Triacetoneamine-N-Oxyl | 2 | 2014 | 2 | 0.140 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 451 | 0.140 |
Why?
| | Microwaves | 1 | 2016 | 36 | 0.140 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 613 | 0.140 |
Why?
| | Cattle | 1 | 2019 | 979 | 0.140 |
Why?
| | Pyrroles | 1 | 2017 | 191 | 0.140 |
Why?
| | Pneumonia | 1 | 2021 | 592 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 564 | 0.130 |
Why?
| | Protons | 1 | 2015 | 79 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 508 | 0.130 |
Why?
| | Spin Trapping | 1 | 2014 | 3 | 0.130 |
Why?
| | Methanol | 1 | 2014 | 35 | 0.130 |
Why?
| | Mice | 6 | 2022 | 15528 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 709 | 0.130 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 576 | 0.120 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2015 | 140 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1096 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 637 | 0.120 |
Why?
| | Hydrogen Bonding | 1 | 2014 | 146 | 0.120 |
Why?
| | Magnetics | 1 | 2014 | 38 | 0.120 |
Why?
| | Hydroxyl Radical | 1 | 2014 | 94 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2016 | 2874 | 0.120 |
Why?
| | Transducers | 1 | 2014 | 27 | 0.120 |
Why?
| | Glutathione | 1 | 2015 | 324 | 0.120 |
Why?
| | Molecular Imaging | 1 | 2014 | 54 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 907 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 963 | 0.120 |
Why?
| | Indicators and Reagents | 4 | 2014 | 100 | 0.110 |
Why?
| | Models, Biological | 1 | 2020 | 1715 | 0.110 |
Why?
| | Animals | 7 | 2022 | 33399 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1974 | 0.100 |
Why?
| | Ethanol | 1 | 2014 | 575 | 0.090 |
Why?
| | Nitrogen Radioisotopes | 3 | 2014 | 6 | 0.090 |
Why?
| | Anisotropy | 3 | 2013 | 65 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1794 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4713 | 0.080 |
Why?
| | HIV Infections | 1 | 2019 | 2461 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3175 | 0.060 |
Why?
| | Time Factors | 1 | 2014 | 6414 | 0.060 |
Why?
| | Nitrogen Isotopes | 2 | 2013 | 55 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 74 | 0.050 |
Why?
| | Humans | 8 | 2022 | 119032 | 0.050 |
Why?
| | Solutions | 2 | 2012 | 156 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 226 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 165 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 44 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2021 | 149 | 0.050 |
Why?
| | Cell Respiration | 1 | 2020 | 76 | 0.050 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.050 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 36 | 0.050 |
Why?
| | Fibrosis | 1 | 2022 | 483 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 95 | 0.040 |
Why?
| | Antioxidant Response Elements | 1 | 2019 | 5 | 0.040 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2019 | 12 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 33 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2020 | 60 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 198 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 53 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 220 | 0.040 |
Why?
| | Water | 2 | 2012 | 425 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 445 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 384 | 0.040 |
Why?
| | Protein Kinases | 1 | 2020 | 310 | 0.040 |
Why?
| | HIV | 1 | 2019 | 210 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 238 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2020 | 339 | 0.040 |
Why?
| | Fibroblasts | 1 | 2022 | 843 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 564 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 900 | 0.040 |
Why?
| | Radionuclide Imaging | 1 | 2016 | 124 | 0.040 |
Why?
| | Up-Regulation | 1 | 2020 | 872 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2025 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 422 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2015 | 59 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 2851 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2014 | 31 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 954 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 72 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2020 | 1063 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 732 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2707 | 0.030 |
Why?
| | Viscosity | 1 | 2013 | 83 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2680 | 0.030 |
Why?
| | Solvents | 1 | 2013 | 118 | 0.030 |
Why?
| | Image Enhancement | 1 | 2014 | 181 | 0.030 |
Why?
| | Apoptosis | 1 | 2022 | 2484 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2275 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1435 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2021 | 3730 | 0.020 |
Why?
| | Isotope Labeling | 1 | 2011 | 76 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2571 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 4914 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 710 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 636 | 0.020 |
Why?
| | Male | 2 | 2021 | 57818 | 0.020 |
Why?
| | Aged | 1 | 2022 | 19661 | 0.010 |
Why?
| | Female | 1 | 2020 | 61588 | 0.010 |
Why?
|
|
Elajaili's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|